| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 7.54 | 110.6% | 12466.7% |
| Total Income | 7.54 | 110.6% | 12466.7% |
| Expenditure | 32.09 | 41.8% | 51.2% |
| PBT | — | ||
| Net Profit | -25.12 | 52.8% | 59.6% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.28 | 55.6% | 62.7% |
Editas Medicine Announces Q3 2025 Financial Results
04 May 2026 · 4 May, 7:32 am
Summary
Editas Medicine, Inc. issued a press release announcing financial results for the fiscal quarter ended September 30, 2025, and other business highlights.
Informational and educational content only. Not investment advice.